Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |